PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · European Journal of General Dentistry 2013; 2(03): 229-234
DOI: 10.4103/2278-9626.115989
Review Article

What dentists should know about oral cancer screening?

Omar B. Kujan
Department of Oral Medicine and Diagnostic Sciences, School of Dentistry, Al-Farabi College, Riyadh, Kingdom of Saudi Arabia, and Oral Pathology, School of Dentistry, Al-Baath University, Hama, Syria
› Author Affiliations
› Further Information
Also available ateRef
 PDF Download Permissions and Reprints
Preview

Abstract

Although the advances in the diagnosis and treatment of oral cancer, it remains one of the most devastating malignancies. Early detection and prevention is a major key in combating policy of cancer. Screening offers an important opportunity for early detection. Several screening methods, visual examination, toluidine blue, fluorescence imaging, and brush biopsy, were used in oral cancer screening programs. General dental practitioner plays an important role in such programs. Therefore, this review aimed to outline the required information, knowledge, and evidence-based practice on oral cancer screening for dentists in order to incorporate this service into their daily routine.

Keywords

Cancer - diagnostic aids - general dentists - oral - screening


Publication History

Article published online:
01 November 2021

© 2013. European Journal of General Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr. [Last accessed on 2013 Feb 10].
  • 2 Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45:309-16.
  • 3 Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh EC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: Causes and solutions. Adv Dent Res 2011;23:237-46.
  • 4 American Cancer Society. Update January 1992: The American Cancer Society guidlines for the cancer-related checkup. CA Cancer J Clin 1992;42:44-5.
  • 5 Sankila R, Coll EC. Evaluation and Monitoring of screening program. Office for the official publication of the European Communities. Luxembourg, 2001. p. 243-54.
  • 6 Chamberlain J, Moss S. Evaluation of Cancer Screening. London: Springer; 1996.
  • 7 Gramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer 1974;34:2018-27.
  • 8 Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644-56.
  • 9 Jatoi I. Breast Cancer Screening. New York: Springer; 1997.
  • 10 Chamberlain J. Evaluation of screening for cancer. Community Dental Health 1993;Suppl 1:5-11.
  • 11 Smart CR. Screening for cancer of the Aerodigestive Tract. Cancer 1993;72:1061-5.
  • 12 Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomised controlled trials. JAMA 1996;276:637-9.
  • 13 Chiodo GT, Eigner T, Rosenstein DI. Oral cancer detection: The importance of routine screening for prolongation of survival. Postgrad Med 1986;80:231-6.
  • 14 Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axéll T, et al. Management of oral epithelial dysplasia: A review. Oral Surg Oral Med Oral Pathol 2007;103 Suppl: S19.e1-12.
  • 15 National Cancer Institute. Oral Cancer (PDQ): Screening Health Professional Version, May 2012. Available from: http://www.cancer.gov/cancertopics/pdq/screening/oral/HealthProfessional. [Last accessed on 2013 Feb 10].
  • 16 Speight PM, Warnakulasuriya S. Evaluation of screening for oral cancer against National Screening Committee Criteria. UK National Screening Committee Publications. 2010. Available from: http://www.screening.nhs.uk/oralcancer. [Last accessed on 2013 Feb 10].
  • 17 Hawkins RJ, Wang EL, Leake JL. Preventive Health Care, 1999 Update: Prevention of oral cancer mortality. J Can Dent Assoc 1999;65:617.
  • 18 Santana JC, Delgade L, Miranda J, Sanchez M. Oral cancer case finding program (OCCFP). Oral Oncol 1997;33:10-2.
  • 19 Opportunistic oral cancer screening: A management for dental practice. BDA Occasional Paper 6, 2000. Available from: http://www.bda.org/Images/mouth_cancer.pdf. [Last accessed on 2013 Feb 12].
  • 20 Lim K, Moles DR, Downer MC, Speight PM. Opportunistic screening for oral cancer and precancer in general dental practice: Results of a demonstration study. Br Dent J 2003;194:497-502.
  • 21 Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol 2000;36:340-6.
  • 22 Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, et al. Early finding from a community-based, cluster-randomised, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 2000;88:664-73.
  • 23 Field EA, Morrison T, Darling AE, Parr TA, Zakrzewska JM. Oral mucosal screening as an integral part of routine dental care. Br Dent J 1995;179:262-6.
  • 24 Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg JJ. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 1986;9:219-25.
  • 25 Warnakulasuriya KA, Pindborg JJ. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Commun Dent Health 1990;7:73-9.
  • 26 Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. B J Cancer 1997;76:390-4.
  • 27 Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahé C, et al. Interim results from a cluster randomised controlled oral cancer screening trial in Kerala, India. Oral Oncol 2003;39:580-8.
  • 28 Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol 1991;19:160-3.
  • 29 Downer MC, Evans AW, Hughes Hallet CM, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol 1995;23:84-8.
  • 30 Ikeda N, Downer MC, Ishii T, Fukano H, Nagao T, Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dent Health 1995;12:133-7.
  • 31 Jullien JA, Downer MC, Zakrzewska JM, 1Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health 1995;12:3-7.
  • 32 Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Thomas G, Anju G, et al. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol 2013;49:314-21.
  • 33 Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al.; Trivandrum Oral Cancer Screening Study Group. Effect of screening on oral cancer mortality in Kerala, India: A cluster-randomised controlled trial. Lancet 2005;365:1927-33.
  • 34 Richart RM. A clinical staining test for the in vivo delineation of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1962;86:703-12.
  • 35 Cancela-Rodríguez P, Cerero-Lapiedra R, Esparza-Gómez G, Llamas-Martínez S, Warnakulasuriya S. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions. J Oral Pathol Med 2011;40:300-4.
  • 36 Herlin P, Marnay J, Jacob JH, Ollivier JM, Mandard AM. A study of the mechanism of staining of the toluidine blue dye test. Endoscopy 1983;15:4-7.
  • 37 Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol 1998;85:444-6.
  • 38 Upadhyay J, Rao NN, Upadhyay RB, Agarwal P. Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions-time to reconsider. Asian Pac J Cancer Prev 2011;12:1757-60.
  • 39 Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol 2001;91:535-40.
  • 40 Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol 1997;83:537-47.
  • 41 Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc 1999;130:1445-57.
  • 42 Christian DC. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. J Am Dent Assoc 2002;133:357-62.
  • 43 Poate TW, Buchanan JA, Hodgson TA, Speight PM, Barrett AW, Moles DR, et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 2004;40:829-34.
  • 44 Kämmerer PW, Koch FP, Santoro M, Babaryka G, Biesterfeld S, Brieger J, et al. Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy. Oral Oncol 2013. pii: S1368-8375 (12) 00392-2.
  • 45 Palcic B, Lam S, Hung J, MacAulay C. Detection and localization of early lung cancer by imaging techniques. Chest 1991;99:742-3.
  • 46 Kluftinger AM, Davis NL, Quenville NF, Lam S, Hung J, Palcic B. Detection of squamous cell cancer and pre-cancerous lesions by imaging of tissue autofluorescence in the hamster cheek pouch model. Surg Oncol 1992;1:183-8.
  • 47 Betz CS, Stepp H, Janda P, Arbogast S, Grevers G, Baumgartner R, et al. A Comparative study of normal inspection, autofluorescence and 5-ala-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer 2002;97:245-52.
  • 48 Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: An adjunct for oral mucosal examinations. J Clin Dent 2006;17:59-63.
  • 49 Seoane Lestón J, Diz Dios P. Diagnostic clinical aids in oral cancer.Oral Oncol 2010;46:418-22.
  • 50 McIntosh L, McCullough MJ, Farah CS. The assessment of diffused light illumination and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions. Oral Oncol 2009;45:e227-31.
  • 51 Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol 2011;47:274-7.
  • 52 McNamara KK, Martin BD, Evans EW, Kalmar JR. The role of direct visual fluorescent examination (VELscope) in routine screening for potentially malignant oral mucosal lesions. Oral Surg Oral Med Oral Pathol 2012;114:636-43.
  • 53 McGee S, Mirkovic J, Mardirossian V, Elackattu A, Yu CC, Kabani S, et al. Model-based spectroscopic analysis of the oral cavity: Impact of anatomy. J Biomed Opt 2008;13:064034.
  • 54 Schwarz RA, Gao W, Stepanek VM, Le TT, Bhattar VS, Williams MD, et al. Prospective evaluation of a portable depth-sensitive optical spectroscopy device to identify oral neoplasia. Biomed Opt Express 2010;2:89-99.
  • 55 Pierce MC, Schwarz RA, Bhattar VS, Mondrik S, Williams MD, Lee JJ, et al. Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia. Cancer Prev Res (Phila) 2012;5:801-9.